Craig Plauschinat

1.6k total citations
29 papers, 1.3k citations indexed

About

Craig Plauschinat is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Craig Plauschinat has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Family Practice and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Craig Plauschinat's work include Medication Adherence and Compliance (8 papers), Diabetes Management and Research (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Craig Plauschinat is often cited by papers focused on Medication Adherence and Compliance (8 papers), Diabetes Management and Research (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Craig Plauschinat collaborates with scholars based in United States, Switzerland and United Kingdom. Craig Plauschinat's co-authors include Michael Dickson, Ken Wong, Jacquelyn Hunt, Yelena Rozenfeld, Joshua McHale, Andrine R. Swensen, Mei Sheng Duh, Edmond L. Toy, Dong‐Churl Suh and W.J. Elliott and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Geriatrics Society and Journal of Hypertension.

In The Last Decade

Craig Plauschinat

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Plauschinat United States 18 455 384 330 310 234 29 1.3k
J. David Powers United States 17 295 0.6× 230 0.6× 178 0.5× 958 3.1× 197 0.8× 39 2.0k
Karen A. Grace United States 10 479 1.1× 455 1.2× 104 0.3× 400 1.3× 55 0.2× 15 1.5k
Pankaj Gupta United Kingdom 18 166 0.4× 344 0.9× 115 0.3× 739 2.4× 89 0.4× 63 1.4k
Mary Rose Stang Canada 14 255 0.6× 69 0.2× 556 1.7× 414 1.3× 234 1.0× 16 1.5k
Tracey H. Taveira United States 20 457 1.0× 120 0.3× 84 0.3× 242 0.8× 110 0.5× 41 1.2k
Amit D. Raval United States 21 332 0.7× 103 0.3× 191 0.6× 156 0.5× 77 0.3× 80 1.3k
Jenifer Wogen United States 12 291 0.6× 115 0.3× 102 0.3× 137 0.4× 121 0.5× 28 714
Marianna Alacqua Italy 13 70 0.2× 288 0.8× 237 0.7× 423 1.4× 269 1.1× 22 1.1k
Lucas Van Bortel Belgium 14 116 0.3× 108 0.3× 178 0.5× 159 0.5× 177 0.8× 33 768
Nicola Motterlini Ireland 19 248 0.5× 64 0.2× 102 0.3× 255 0.8× 91 0.4× 31 1.3k

Countries citing papers authored by Craig Plauschinat

Since Specialization
Citations

This map shows the geographic impact of Craig Plauschinat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Plauschinat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Plauschinat more than expected).

Fields of papers citing papers by Craig Plauschinat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Plauschinat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Plauschinat. The network helps show where Craig Plauschinat may publish in the future.

Co-authorship network of co-authors of Craig Plauschinat

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Plauschinat. A scholar is included among the top collaborators of Craig Plauschinat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Plauschinat. Craig Plauschinat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moseley, Brian D., Shaloo Gupta, Jonathan P. Wright, et al.. (2022). Patient-Reported Outcome Measures in Adult Patients Diagnosed with Epilepsy Being Treated with Perampanel. SHILAP Revista de lepidopterología. 2 indexed citations
2.
3.
Li, Xuan, Feride Frech, Craig Plauschinat, & Mugdha Gore. (2020). Real-world hospitalization risk in patients with epilepsy treated with perampanel. Epilepsy & Behavior. 114(Pt A). 107270–107270. 6 indexed citations
4.
Martínez, Cristina, Craig Plauschinat, Nicholas D. Giardino, et al.. (2012). Gender Differences in Symptoms and Care Delivery for Chronic Obstructive Pulmonary Disease. Journal of Women s Health. 21(12). 1267–1274. 52 indexed citations
5.
Plauschinat, Craig, et al.. (2012). Failure to Intensify Hypertension Therapy After Rejected Aliskiren Claims. Clinical Therapeutics. 34(5). 1122–1131. 3 indexed citations
6.
Kozma, Chris M, et al.. (2011). Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study. BMC Pulmonary Medicine. 11(1). 61–61. 12 indexed citations
7.
Plauschinat, Craig, et al.. (2011). Economic impact of using inhaled corticosteroids without prior exacerbation among elderly patients with chronic obstructive pulmonary disorder. Journal of Medical Economics. 14(4). 458–462. 6 indexed citations
8.
9.
10.
Suh, Dong‐Churl, Chul-Min Kim, In‐Sun Choi, Craig Plauschinat, & Joseph A. Barone. (2009). Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004. Journal of Hypertension. 27(9). 1908–1916. 60 indexed citations
11.
Rozenfeld, Yelena, Jacquelyn Hunt, Craig Plauschinat, & Ken Wong. (2008). Oral antidiabetic medication adherence and glycemic control in managed care.. PubMed. 14(2). 71–5. 210 indexed citations
12.
Barron, John, Peter Wahl, Maxine D. Fisher, & Craig Plauschinat. (2008). Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications.. PubMed. 33(9). 532–53. 30 indexed citations
13.
Suh, Dong‐Churl, et al.. (2008). Comorbid Conditions and Glycemic Control in Elderly Patients with Type 2 Diabetes Mellitus, 1988 to 1994 to 1999 to 2004. Journal of the American Geriatrics Society. 56(3). 484–492. 40 indexed citations
14.
Asche, Carl V., et al.. (2008). Evaluation of Adverse Events of Oral Antihyperglycaemic Monotherapy Experienced by a Geriatric Population in a Real-World Setting. Drugs & Aging. 25(7). 611–622. 13 indexed citations
15.
16.
Dickson, Michael & Craig Plauschinat. (2008). Compliance with Antihypertensive Therapy in the Elderly. American Journal of Cardiovascular Drugs. 8(1). 45–50. 84 indexed citations
17.
Patel, Bimal V., Rosemay A. Remigio‐Baker, Patrick Thiebaud, Ronald Preblick, & Craig Plauschinat. (2008). Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy. BMC Family Practice. 9(1). 61–61. 25 indexed citations
18.
Asche, Carl V., Carrie McAdam‐Marx, Laura Shane‐McWhorter, Xiaoming Sheng, & Craig Plauschinat. (2007). Association between oral antidiabetic use, adverse events and outcomes in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 10(8). 638–645. 30 indexed citations
19.
Riedel, Aylin, Herbert C. Heien, Jenifer Wogen, & Craig Plauschinat. (2007). Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione Monotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(8). 1102–1110. 71 indexed citations
20.
Elliott, W.J., et al.. (2007). Persistence, Adherence, and Risk of Discontinuation Associated with Commonly Prescribed Antihypertensive Drug Monotherapies. The Journal of the American Board of Family Medicine. 20(1). 72–80. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. David Powers Breakdown of academic impact, for papers by Karen A. Grace Breakdown of academic impact, for papers by Pankaj Gupta Breakdown of academic impact, for papers by Mary Rose Stang Breakdown of academic impact, for papers by Tracey H. Taveira Breakdown of academic impact, for papers by Amit D. Raval Breakdown of academic impact, for papers by Jenifer Wogen Breakdown of academic impact, for papers by Marianna Alacqua Breakdown of academic impact, for papers by Lucas Van Bortel Breakdown of academic impact, for papers by Nicola Motterlini
Rankless by CCL
2026